PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,807,000 | +89.2% | 169,066 | +66.3% | 0.20% | +70.4% |
| Q4 2014 | $955,000 | -29.0% | 101,686 | -42.0% | 0.12% | -19.6% |
| Q3 2014 | $1,346,000 | -63.1% | 175,261 | -56.8% | 0.14% | -59.4% |
| Q2 2014 | $3,646,000 | +53.5% | 405,980 | -8.6% | 0.35% | +46.1% |
| Q1 2014 | $2,375,000 | – | 443,970 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,010,000 | $905,000 | 0.21% |
| GLOBEFLEX CAPITAL L P | 226,959 | $102,000 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 62,800 | $28,000 | 0.01% |
| MENTA CAPITAL LLC | 195,136 | $87,000 | 0.01% |
| Orbimed Advisors | 1,073,000 | $481,000 | 0.01% |
| GOODWIN DANIEL L | 22,679 | $10,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 215,800 | $97,000 | 0.00% |
| Renaissance Technologies | 2,214,396 | $992,000 | 0.00% |
| STOCK YARDS BANK & TRUST CO | 30,170 | $14,000 | 0.00% |
| HIGHLAND CAPITAL MANAGEMENT, LLC | 41,000 | $18,000 | 0.00% |